Area of research
Public Health, Environmental and Occupational Health · Pediatrics, Perinatology and Child Health
Research interest
Research focused on Lymphoblastic Leukemia and Oncology, with related work in Minimal residual disease, Genetics, Genetic predisposition. Notable publications include 'Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031', 'Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse', and 'Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia'.
The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia
Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report
Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia
Outcome of Children with Standard‐Risk T‐Lineage Acute Lymphoblastic Leukemia—Comparison among Different Treatment Strategies
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3)
Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children’s Oncology Group Study AALL0031
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse
Novel Susceptibility Variants at 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically Diverse Populations
Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients With Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia
Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia
Imatinib resistant <i>BCR</i>‐<i>ABL1</i> mutations at relapse in children with <scp>P</scp>h<sup>+</sup><scp>ALL</scp>: a <scp>C</scp>hildren's <scp>O</scp>ncology <scp>G</scp>roup (<scp>COG</scp>) study
Cardioprotection and safety of dexrazoxane (DRZ) in children treated for newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or advanced stage lymphoblastic leukemia (T-LL).